A-D
1 years ago-Biopharma Group
1 years ago-BioGenes GmbH

SMi’s 10th Annual Biosimilars Conference

Views: 83

Conference:  Wednesday 25 and Thursday 26 September 2019

Workshop: Tuesday 24th September 2019

Location: Copthorne Tara Hotel, London, UK

Website: www.biosimilars-europe.com/

Chaired by Michel Mikhail, International Expert Regulatory Affairs, Global Expert Biosimilars

Forecasting future regulatory, commercial & legal challenges to advance biosimilars uptake

SMi Group are delighted to announce the 10th annual Biosimilars Conference taking place on 25th and 26th September 2019. This year’s event will be our first global event taking place in London, UK. The event’s focus is to highlight the current challenges in the biosimilars market and discuss current undergoing plans or developments to overcome these challenges.

The biosimilars market is forecasted to reach USD$23.6B by 2023 at a compound annual growth rate (CAGR) of 31.70%. Factors driving the increase of this market include growing demand for biosimilar drugs due to their cost-effectiveness, growing incidence of chronic diseases, and strategic collaborations resulting in enhanced productivity and clinical trial activities.

 

With the expiry dates of major patents fast approaching, the emerging gap in the market for biosimilars is now a major attraction for manufacturers. As the availability of biosimilars could potentially reduce direct spending by USD$54B by 2026, the question is what can current biosimilar producing companies do to join this market to benefit the patients, physicians and investors?

 

BENEFITS OF ATTENDING

 

  • HEAR about current strategies under development to overcome challenges with patents currently faced by many biosimilar developers
  • DISCUSS the possible changes in regulatory approval of biosimilars in the UK post-Brexit, and how this will impact market entry
  • EXPLORE the latest methods in use to maintain the relationship between stakeholders, doctors and patients, with the influence of governing bodies
  • REVIEW FDA regulations for the approval of Biosimilars and the latest approvals

 

PLUS, TWO INTERACTIVE HALF-DAY PRE-CONFERENCE WORKSHOPS

Tuesday 24th September 2019, Copthorne Tara Hotel, Central London, UK

 

A: US-FDA Interchangeability Guideline

08.30 – 12.30

Workshop Leader: Michel Mikhail, International Expert Regulatory Affairs, Global Expert of Biosimilars

 

B: Advancing biosimilars development and uptake in MENA & GCC regions

13:30 – 17:30

Workshop Leader: Rodeina Challand, General Manager, Challand Biosimilar Consulting

 

WHO SHOULD ATTEND?

Presidents, Vice Presidents, Managing Directors, Directors, Associate Directors, Chiefs, Heads, Principals, Managers and Analysts of:

 

Biosimilar Development

Product Development

Commercialization

Market Access

Medical Affairs

Intellectual Property

Biologics

Biopharmaceuticals

Research and Development

Generics

Biobetters

Business Development

Strategic Marketing

Drug Development

Clinical Trials

Immunogenicity Studies

 

Global Presence: Attendees from all over the world attend our events. Gain hands-on insight from representatives from the UK, Europe and USA.

For details and to register, visit the website at www.biosimilars-europe.com/ or contact the team at +44(0) 207 827 6000, email ssapal@smi-online.co.uk

 

EARLY BIRD-RATES

  • BOOK BY 28TH JUNE AND SAVE £200

 

SOCIAL MEDIA HANDLES

 

Twitter: @SMiPharm

Event Hashtag: #SMiBioSimilars

LinkedIn: follow our company page – search ‘SMi Pharma’

Comments: 0

Your email address will not be published. Required fields are marked with *

0

Your Cart